|
|
 |
 |
| |
广西福华制药有限公司始建于一九九三年，是玉林市卫生学校和香港福华出人口贸易公司合资兴办的集科研、生产、经营于一家的中外合资制药企业。生产各种合剂.药剂.主要产品有治疗甲状腺机能亢进症新药纯中药制剂石麦清合剂（原名甲亢舒液)。
我公司自行开发、独家生产的治疗甲亢新药石麦清合剂（原名甲亢舒液），经多家省级医院临床治疗验证，对甲状腺机能亢进症和阴虚症的治疗总有效率为93．3％。并通过国家药品审评中心的评审，获得国家药品监督管理局颁发的国药推字号批文。石麦清合剂对轻、中度甲亢的治疗效果显著，配合I131治疗甲亢能有效地减少并发症发生，且不影响甲状腺对碘的吸收，填补了停药后的“空白区”，使病人平稳过渡。产品远销上海、山东、辽宁、吉林、山西、福建、浙江、湖南、湖北、河南、河北、四川、贵州、云南、广东、海南、江西等地，在广大患者中享有较高的声誉。石麦清合剂（原名甲亢舒液）曾获玉林地区科技进步二等奖。我公司科研人员主持的“石麦清合剂（原名甲克舒液）配合I131治疗甲状腺机能亢进的临床应用研究”荣获玉林市科技进步二等奖。公司荣获一九九六年度全国卫生产业先进单位。
公司目前有合剂、胶囊剂、酒剂、片剂的生产设备和先进的检验仪器，技术力量雄厚，固定资产800多万元，是全国最大的校办中外合资企业之一。作为纯中药制剂治疗甲亢病的石麦清合剂疗效显著，其中不影响碘吸收是本产品的一大特点。是当前市场上没有任何产品能替代石麦清合剂的功能和作用的中成药，因此石麦治合剂具有良好的发展前景和优势。石麦清合剂自投产以来，累计创造利润500多万元，上交税收300多万元，取得了较好的社会效益和经济效益。公司投资1000万元新建符合GMP要求、年产值1．2亿元的现代化厂房目前已顺利通过GMP验收。公司目前致力开发科技含量高的治疗甲亢的系列纯中药制剂，不断开发市场，争取更好的社会效益和经济效益，为发展医药卫生事业、造福人类做出更大的贡献。
Guangxi good fortune China pharmacy Co., Ltd. was established in 1993, it is Yulin city health school and Hong Kong good fortune China that produce people trading company collection scientific research, production that joint-venture set up, manage on of Sino-foreign joint venture pharmacy enterprises. Produce various kinds of mixture. Drug. The main products treat the clear mixture of stone and wheat of pure traditional Chinese medicine preparation of new medicine of hyperthyroidism and disease (originally known as first overbearing easy liquid).
Clear mixture of first overbearing new medicines and stone needles wheat of treatment which our company develops , produces without competition by oneself (originally known as first overbearing easy liquid), treat proving clinically , it is 93 that the treatment of the hyperthyroidism and disease and deficiency of Yin and disease is always efficient through many provincial hospitals. 3%. And examine the evaluation which comment the centre through the national medicines , get traditional Chinese medicines that State Pharmaceutical Inspection Administration issues and push shop"s written instructions or comments. Stone there is clear for mixture wheat to the light, in spend because first overbearing result of treatment the remarkable, cooperate with I131 not to be treated first the overbearing to can reduce there aren"t complication effectively, and does not influence the absorption of the iodine of thyroid gland , " blank district " after filling in medicines of stopping , make patient"s smooth transition.The products find a good sale in Shanghai, Shandong , Liaoning , Jilin , Shanxi , Fujian , Zhejiang , Hunan , Hubei , Henan , Hebei , Sichuan , Guizhou , Yunnan , Guangdong , Hainan , Jiangxi and other places, enjoy higher reputation among patients . The clear mixture of stone and wheat (originally known as first overbearing easy liquid ) has obtained the scientific and technological progress second prize of Yulin Prefecture. " clear mixture of stone and wheat " which the scientific research personnel of our company presided over (originally known as first gram of easy liquid) the clinical application study of cooperating with I131 to treat the hyperthyroidism " win the scientific and technological progress second prize of Yulin. The company wins the industry advanced unit of the national hygiene in 1996.
There are mixture , capsule pharmaceutical , wine pharmaceutical , the production equipment of the tablet and advanced inspection instrument at present in the company, technical force is rich, fixed assets are more than 8 million yuan, is one of the largest school-run Sino-foreign joint ventures of the whole country. As stone wheat clear mixture curative effect of treating first overbearing disease of pure traditional Chinese medicine preparation being remarkable, among them not influence the iodine to absorb a great characteristic that is a product . There are no function that any products can substitute the clear mixture of stone and wheat and Chinese patent drugs on function on the market at present, so the stone and wheat manage the mixture have good development prospect and advantage. Since the clear mixture of stone and wheat went into operation , had created the profit of more than 5 million yuan totally, submit tax revenue of more than 3 million yuan, have made better social benefit and economic benefits. It accords with GMP demand , annual output 1 that the company invests newly-built 10 million yuan. The modernized factory building at 200 million yuan has already been confirmed smoothly through GMP at present. The company is devoted to developing first overbearing serial pure traditional Chinese medicine preparation of treatment high in scientific and technological content at present, developing the market constantly, strive for better social benefit and economic benefits, in order to develop medical hygiene industry , promote the well-being of mankind to make greater contribution.
|
| |
|
|
